Founded in 2020, Innovodigm operates in Health Tech offering new technologies to improve healthcare. The company is a biomedical startup based in Kolkata, concentrating on developing innovative soluti...
Funding stage:
Seed
Last funding:
23/06/2025
Total funding:
$643.38K+
Revenue:
Investors
Employee count:
5
Last 90d
5
Last 90d
Web traffic:
326
326
Last 30d
Last 30d
Innovodigm: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders5
Latest Filing Date01 June 2025- Funding Events3
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Innovodigm
As of 02 June 2025, Innovodigm's equity is held by 4 shareholders, with the top three being Ayan Chatterjee, Jhimli Sarkar Manna, and Ian Capital.
Ayan Chatterjee holds the largest stake in Innovodigm at 40.4% as of 02 June 2025.
As of 02 June 2025, founders collectively hold 80.8% equity in Innovodigm.
As of 02 June 2025, investors collectively hold 8.5% equity in Innovodigm.
Innovodigm's ESOP pool stands at 10.7% of total equity as of 02 June 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links